Barbara A. Weir

44.3k citations

46 papers · 4.1k indexed · 1 hit paper · h-index 29

Molecular Biology top 5%
Cancer Research top 1%
Oncology top 2%
Pulmonary and Respiratory Medicine top 2%
Genetics top 5%

Co-authors: Matthew Meyerson Rameen Beroukhim Travis Zack William C. Hahn D. W. Sundstrom David Pellman Gad Getz Wendy Winckler
Topics: Cancer Genomics and Diagnostics (9 papers)Lung Cancer Treatments and Mutations (6 papers)Genomic variations and chromosomal abnormalities (6 papers)
Cited by: Cancer Research Oncology Molecular Biology
Journals: Cell Proceedings of the National Academy of Sciences Journal of Clinical Oncology
Partner nations: United States Australia Japan

In The Last Decade

Barbara A. Weir

45 papers receiving 4.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Absolute quantification of somatic DNA alterations in human cancer

2012 1.1k citations Scott L. Carter, Travis Zack et al. profile →

Peers

Countries citing papers authored by Barbara A. Weir

Since Specialization

Citations

This map shows the geographic impact of Barbara A. Weir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara A. Weir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara A. Weir more than expected).

Fields of papers citing papers by Barbara A. Weir

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara A. Weir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara A. Weir. The network helps show where Barbara A. Weir may publish in the future.

Co-authorship network of co-authors of Barbara A. Weir

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara A. Weir. A scholar is included among the top collaborators of Barbara A. Weir based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara A. Weir. Barbara A. Weir is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	PRMT1-Mediated Translation Regulation Is a Crucial Vulnerability of Cancer 2017 ·Cancer Research ·Jessie Hao-Ru Hsu,(unknown),Guillaume Adelmant,Jialiang Huang,Cailin E. Joyce,Francisca Vázquez,Barbara A. Weir,Philip Montgomery,Aviad Tsherniak,Andrew O. Giacomelli,Jennifer A. Perry,Jennifer J. Trowbridge,Yuko Fujiwara,Glenn S. Cowley,Huafeng Xie,Woojin Kim,Carl D. Novina,William C. Hahn,Jarrod A. Marto,Stuart H. Orkin	26
2	Identification of an “Exceptional Responder” Cell Line to MEK1 Inhibition: Clinical Implications for MEK-Targeted Therapy 2015 ·Molecular Cancer Research ·Hugh Gannon,Nathan O. Kaplan,Aviad Tsherniak,Francisca Vázquez,Barbara A. Weir,William C. Hahn,Matthew Meyerson	19
3	The Tyrosine Kinase Adaptor Protein FRS2 Is Oncogenic and Amplified in High-Grade Serous Ovarian Cancer 2014 ·Molecular Cancer Research ·Leo Y. Luo,Eejung Kim,Hiu Wing Cheung,Barbara A. Weir,Gavin P. Dunn,Rhine R. Shen,William C. Hahn	29
4	Resistance to CDK2 Inhibitors Is Associated with Selection of Polyploid Cells in CCNE1 -Amplified Ovarian Cancer 2013 ·Clinical Cancer Research ·Dariush Etemadmoghadam,George Au‐Yeung,Meaghan Wall,Thomas J. Mitchell,Maya Kansara,Elizabeth Loehrer,(unknown),Joshy George,Sarah Ftouni,Barbara A. Weir,Scott L. Carter,Irma Gresshoff,Linda Mileshkin,Danny Rischin,William C. Hahn,Paul Waring,Gad Getz,Carleen Cullinane,Lynda J. Campbell,David D.L. Bowtell	90
5	Synthetic lethality between CCNE1 amplification and loss of BRCA1 2013 ·Proceedings of the National Academy of Sciences ·Dariush Etemadmoghadam,Barbara A. Weir,George Au‐Yeung,Kathryn Alsop,Gillian Mitchell,Joshy George,(unknown),(unknown),Alan D. D’Andrea,Kaylene J. Simpson,William C. Hahn,David D.L. Bowtell	157
6	An integrative analysis reveals functional targets of GATA6 transcriptional regulation in gastric cancer 2013 ·Oncogene ·Rita Sulahian,Fergal Casey,Jie Shen,Zhirong Qian,Hyunjin Shin,Shuji Ogino,Barbara A. Weir,Francisca Vázquez,Xiaole Shirley Liu,William C. Hahn,Adam J. Bass,Vivian Chan,Ramesh A. Shivdasani	48
7	Targeted Tumor-Penetrating siRNA Nanocomplexes for Credentialing the Ovarian Cancer Oncogene ID4 2012 ·Science Translational Medicine ·Yin Ren,Hiu Wing Cheung,(unknown),Amit Agrawal,Glenn S. Cowley,Barbara A. Weir,Jesse S. Boehm,Pablo Tamayo,Alison M. Karst,Joyce F. Liu,Michelle S. Hirsch,Jill P. Mesirov,Ronny Drapkin,David E. Root,Justin H. Lo,Valentina Fogal,Erkki Ruoslahti,William C. Hahn,Sangeeta N. Bhatia	134
8	Cancer Vulnerabilities Unveiled by Genomic Loss 2012 ·Cell ·Deepak Nijhawan,Travis Zack,Yin Ren,Matthew R. Strickland,Rebecca Lamothe,Steven E. Schumacher,Aviad Tsherniak,Henrike C. Besche,Joseph Rosenbluh,Shyemaa Shehata,Glenn S. Cowley,Barbara A. Weir,Alfred L. Goldberg,Jill P. Mesirov,David E. Root,Sangeeta N. Bhatia,Rameen Beroukhim,William C. Hahn	161
9	Targeted Tumor-Penetrating siRNA Nanocomplexes for Credentialing the Ovarian Cancer Target ID4 2012 ·DSpace@MIT (Massachusetts Institute of Technology) ·Yin Ren,(unknown),Amit Agrawal,Jill P. Mesirov,Justin H. Lo,Sangeeta N. Bhatia,Hiu Wing Cheung,Glenn S. Cowley,Barbara A. Weir,Jesse S. Boehm,Pablo Tamayo,Alison M. Karst,Joyce F. Liu,Michelle S. Hirsch,Ronny Drapkin,David E. Root,Valentina Fogal,Erkki Ruoslahti,William C. Hahn	2
10	ATARiS: Computational quantification of gene suppression phenotypes from multisample RNAi screens 2012 ·Genome Research ·Diane D. Shao,Aviad Tsherniak,Shuba Gopal,Barbara A. Weir,Pablo Tamayo,Nicolas Stransky,Steven E. Schumacher,Travis Zack,Rameen Beroukhim,Levi A. Garraway,Adam A. Margolin,David E. Root,William C. Hahn,Jill P. Mesirov	78
11	Amplification of CRKL Induces Transformation and Epidermal Growth Factor Receptor Inhibitor Resistance in Human Non–Small Cell Lung Cancers 2011 ·Cancer Discovery ·Hiu Wing Cheung,Jinyan Du,Jesse S. Boehm,Frank He,Barbara A. Weir,Xiaoxing Wang,Mohit Butaney,Lecia V. Sequist,Biao Luo,Jeffrey A. Engelman,David E. Root,Matthew Meyerson,Todd R. Golub,Pasi A. Jänne,William C. Hahn	110
12	PAK1 is a breast cancer oncogene that coordinately activates MAPK and MET signaling 2011 ·Oncogene ·Yashaswi Shrestha,Eric J. Schafer,Jesse S. Boehm,Sapana Thomas,Frank He,Jinyan Du,Shumei Wang,Jordi Barretina,Barbara A. Weir,Jean J. Zhao,Kornélia Polyák,Todd R. Golub,Rameen Beroukhim,William C. Hahn	124
13	Clinical significance of TTF‐1 protein expression and TTF‐1 gene amplification in lung adenocarcinoma 2008 ·Journal of Cellular and Molecular Medicine ·Justine A. Barletta,Sven Perner,A. John Iafrate,Beow Y. Yeap,Barbara A. Weir,Laura A. Johnson,Bruce E. Johnson,Matthew Meyerson,Mark A. Rubin,William D. Travis,Massimo Loda,Lucian R. Chirieac	82
14	The major lung cancer-derived mutants of ERBB2 are oncogenic and are associated with sensitivity to the irreversible EGFR/ERBB2 inhibitor HKI-272 2007 ·Oncogene ·Yuko Minami,Takeshi Shimamura,Kinjal Shah,Thomas LaFramboise,Karen A. Glatt,Elizabeth Liniker,Christa L. Borgman,Henry J. Haringsma,William W. Feng,Barbara A. Weir,April M. Lowell,Jean C. Lee,Juergen Wolf,Geoffrey I. Shapiro,Kwok‐Kin Wong,Matthew Meyerson,Reji Koshy Thomas	88
15	Homozygous Deletions and Chromosome Amplifications in Human Lung Carcinomas Revealed by Single Nucleotide Polymorphism Array Analysis 2005 ·Cancer Research ·Xiaojun Zhao,Barbara A. Weir,Thomas LaFramboise,Ming Gang Lin,Rameen Beroukhim,Levi A. Garraway,Javad Beheshti,Jeffrey C. Lee,Katsuhiko Naoki,William G. Richards,David J. Sugarbaker,Fei Chen,Mark A. Rubin,Pasi A. Jänne,Luc Girard,John D. Minna,David C. Christiani,Cheng Li,William R. Sellers,Matthew Meyerson	242
16	Mmd1p, a Novel, Conserved Protein Essential for Normal Mitochondrial Morphology and Distribution in the Fission YeastSchizosaccharomyces pombe 2004 ·Molecular Biology of the Cell ·Barbara A. Weir,Michael P. Yaffe	42
17	Somatic alterations in the human cancer genome 2004 ·Cancer Cell ·Barbara A. Weir,Xiaojun Zhao,Matthew Meyerson	120
18	Evidence for two types of subunits in the bacterioferritin of Magnetospirillum magnetotacticum 1997 ·Gene ·L. Elizabeth Bertani,(unknown),Barbara A. Weir,Joseph L. Kirschvink	24
19	Destruction of Benzene by Ultraviolet Light-Catalyzed Oxidation with Hydrogen Peroxide 1987 ·Hazardous Waste and Hazardous Materials ·Barbara A. Weir,D. W. Sundstrom,Herbert E. Klei	31
20	Destruction of Halogenated Aliphatics by Ultraviolet Catalyzed Oxidation with Hydrogen Peroxide 1986 ·Hazardous Waste and Hazardous Materials ·D. W. Sundstrom,Herbert E. Klei,(unknown),(unknown),Barbara A. Weir	71

About Barbara A. Weir

Barbara A. Weir is a scholar working on Cancer Research, Industrial and Manufacturing Engineering and Reproductive Medicine, having authored 46 papers that have together received 4.1k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (9 papers), Lung Cancer Treatments and Mutations (6 papers) and Genomic variations and chromosomal abnormalities (6 papers). The work is most often cited by research in Cancer Research (1.4k citations), Oncology (1.0k citations) and Molecular Biology (2.4k citations). Barbara A. Weir has collaborated with scholars based in United States, Australia and Japan. Frequent co-authors include Matthew Meyerson, Rameen Beroukhim, Travis Zack, William C. Hahn, D. W. Sundstrom, David Pellman, Gad Getz, Wendy Winckler, Scott L. Carter and Eric S. Lander. Their work appears in journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact